OCRX

Tranzyme Pharma Announces Top-Line Results of TZP-102 Phase 2b Trial

[at noodls] – Preliminary Analysis Indicates Trial Did Not Meet Primary Endpoint Tranzyme to Host Conference Call Today at 8:00 am ET RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboard […]

Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss third … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboard […]

Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss third … moreView todays social media effects on OCRXView the latest stocks trending across Twitter. Click to view dashboard […]